Predictors of Hospital Readmission for Chronic Obstructive Pulmonary Disease Patients

NCT ID: NCT06348966

Last Updated: 2024-04-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

188 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-05-01

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is aimed to determine the risk factors for hospital readmission within 6 months in COPD patients

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is aimed to determine the risk factors for hospital readmission within 6 months in COPD patients and develop early warning model

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hospital Radmission for COPD Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All COPD patients of both genders diagnosed by (GOLD) Guidelines (2024 Revision).
* Cooprative patients who accept to participate in the current study .

Exclusion Criteria

* patients with cognitive impairment ,and unable to answer needed questions.
* patients with other lung diseases such as active pulmonary tuberculosis ,asthma ,bronchiactesis,and pulmonary embolism .
* patients with incomplete clinical data .
* Refused to participate in the current study .
Minimum Eligible Age

25 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assiut University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rougina Girgis Kamel Boles

resident doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rougina Girgis

Role: CONTACT

01273476615

Entsar Hsanen

Role: CONTACT

01019968106

References

Explore related publications, articles, or registry entries linked to this study.

Alqahtani JS, Aldabayan YS, Aldhahir AM, Al Rajeh AM, Mandal S, Hurst JR. Predictors of 30- and 90-Day COPD Exacerbation Readmission: A Prospective Cohort Study. Int J Chron Obstruct Pulmon Dis. 2021 Oct 7;16:2769-2781. doi: 10.2147/COPD.S328030. eCollection 2021.

Reference Type BACKGROUND
PMID: 34675502 (View on PubMed)

Anbesse ZK, Mega TA, Tesfaye BT, Negera GZ. Early readmission and its predictors among patients treated for acute exacerbations of chronic obstructive respiratory disease in Ethiopia: A prospective cohort study. PLoS One. 2020 Oct 6;15(10):e0239665. doi: 10.1371/journal.pone.0239665. eCollection 2020.

Reference Type BACKGROUND
PMID: 33022006 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

predictors of readmission

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Phenotypes of COPD
NCT03432026 UNKNOWN
Blood Hpercoagublity in Copd
NCT05380960 UNKNOWN